10:35am ET
Health and Healthcare
Short Sellers Back Off Major Biotechs
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
Companies
/Healthcare
Gilead Sciences Inc
$148.09
▼ $0.68 (−0.46%) today
Markets closed · 9:37pm ET
GILD Coverage
Page 244:01pm ET
Investing
Gilead Sciences, DryShips Stuck in Tuesday’s 52-Week Low Club
DryShips, Gilead Sciences, BT Group, and Cascadian Therapeutics made new 52-week lows on Tuesday.
Paul Ausick 4:04pm ET
Investing
Teva, Gilead Sciences Tumble into Monday’s 52-Week Low Club
DryShips, Teva, Endo Pharma, and Gilead Sciences posted new 52-week lows Monday.
9:55am ET
Health and Healthcare
Jefferies Has Cheap Biotech and Pharma Stocks to Buy for 2017
A new Jefferies research report makes the case that while market parameters are indeed expensive, there still are cheap stocks to buy that have a large enough market cap to provide some…
9:35am ET
Health and Healthcare
Biotech Short Sellers Run for Cover
As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what the bears have to say about this rally.
8:35am ET
Health and Healthcare
Jefferies Has 5 Top Biotech Stocks to Buy for 2017
Needless to say, the past two years have been rough on biotech. The question for investors is which of the stocks hold the best potential in 2017.
10:10am ET
Health and Healthcare
Biotech Short Interest Sinks
The December 15 short interest data have been compared with the previous report, and short interest was down in most of the selected biotech stocks.
9:10am ET
Health and Healthcare
Biotech Short Interest Remains Mixed
The November 30 short interest data have been compared with the previous report, and short interest was mixed in the selected biotech stocks.
4:04pm ET
Investing
FitBit, Gilead Sciences in Thursday’s 52-Week Low Club
December 8, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in Thursday’s session. On the NYSE, advancers led decliners by about 3 to…
7:35am ET
Health and Healthcare
Short Sellers Grow More Aggressive on Major Biotechs
The November 15 short interest data have been compared with the previous report, and short interest increased in most of the selected biotech stocks.
1:26pm ET
Health and Healthcare
Gilead Scores Another Hepatitis FDA Approval
Gilead Sciences has announced that the FDA has approved its once-a-day treatment for adults with chronic hepatitis B virus infection.
Jon C. Ogg 7:20am ET
Health and Healthcare
Short Sellers Grow More Selective on Major Biotechs
Now that the U.S. presidential election is over and Hillary Clinton is out of the picture, major biotech companies can breathe a little easier knowing that the pressure is off, if for…
10:20am ET
Health and Healthcare
How Analysts View Value and Opportunity in Gilead After Earnings
If you just looked at formal Buy and Sell ratings from Wall Street analysts, you might assume that everything is still fine and hopeful for Gilead Sciences.
Jon C. Ogg 4:58pm ET
Health and Healthcare
Has Gilead Finally Bottomed?
Gilead Sciences Inc. (NASDAQ: GILD) released third-quarter earnings report after markets closed on Tuesday. Despite negative news coming out on Tuesday with former presidential candidate Bernie Sanders taking a shot at the…
Chris Lange 11:15am ET
Health and Healthcare
What to Expect From Gilead Earnings
Although Gilead has been falling for about a year now, the valuation is looking more favorable — assuming Gilead is not a value trap. The earnings report will help shed some light…
Chris Lange